Pharmacists' provision of continuity of care to patients with human immunodeficiency virus infection

被引:14
作者
Foisy, MM
Tseng, A
Blaikie, N
机构
[1] UNIV TORONTO,DOCTOR PHARM PROGRAM,TORONTO,ON M5S 1A1,CANADA
[2] WELLESLEY HLTH CTR,TORONTO,ON,CANADA
[3] WELLESLEY DRUG STORE,TORONTO,ON,CANADA
关键词
administration; ambulatory care; communication; HIV infections; pharmacy; community; institutional; hospital; research; workload;
D O I
10.1093/ajhp/53.9.1013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A pharmacy program for providing continuity of care to patients infected with the human immunodeficiency virus (HIV) is described. The program was implemented at three practice sites in Toronto: a tertiary care teaching hospital; an outpatient community pharmacy that is part of the hospital; and an ambulatory care clinic affiliated with the hospital. An HIV pharmacy practice was established at the hospital in 1993. The community pharmacy serves at least 30% df the HIV-infected patients in Ontario who are receiving antiretrovirals; patient counseling is emphasized. The ambulatory care clinic's HIV program was established in 1994; the pharmacist sees patients at the clinic or in their homes. To address the need for greater continuity of care, the following issues were addressed: workload involved in providing pharmaceutical care to HIV-infected patients, establishing patient pharmacy profiles common to the three sites, streamlining communication among the sites, creating a process for identifying patient problems in the community setting, collaborating on research and projects, and forging links with other pharmacists caring for HIV-infected patients. The program has enhanced the ability of pharmacists to make informed recommendations and care plans, increased patient follow-up, improved cross-coverage of patients in the absence of an HIV pharmacist, increased sharing of drug information, and led to joint collaboration on projects. A pharmacy program to serve HIV-infected patients was implemented at three sites and successfully integrated under a continuity-of care model.
引用
收藏
页码:1013 / 1017
页数:5
相关论文
共 17 条
[1]  
*CAN I HLTH INF, 1995, 579 AN MCC 24 DISCH
[2]   ALLERGIC MANIFESTATIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION [J].
CARR, A ;
COOPER, DA ;
PENNY, R .
JOURNAL OF CLINICAL IMMUNOLOGY, 1991, 11 (02) :55-64
[3]   ASSESSMENT OF THE PHARMACY SERVICE NEEDS OF HIV-POSITIVE OUTPATIENTS RECEIVING ZIDOVUDINE [J].
GRECO, R ;
LAVACK, L ;
ROVERS, J .
ANNALS OF PHARMACOTHERAPY, 1992, 26 (05) :621-626
[4]  
GREENBLATT RM, 1991, J ACQ IMMUN DEF SYND, V4, P136
[5]   OPPORTUNITIES AND RESPONSIBILITIES IN PHARMACEUTICAL CARE [J].
HEPLER, CD ;
STRAND, LM .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (03) :533-543
[6]  
HONG M, 1995, HOSP PHARM ONT NEWS, V32, P9
[7]  
LAVACK L, 1995, PHARM CONNECT, V2, P4
[8]   INTERACTIONS AND TOXICITIES OF DRUGS USED IN PATIENTS WITH AIDS [J].
LEE, BL ;
SAFRIN, S .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (03) :773-779
[9]  
MARTIN S, 1992, AM PHARM, V32, pN45
[10]   THE ROLE OF PHARMACISTS IN AIDS CARE DELIVERY [J].
OKE, TO .
AIDS PATIENT CARE, 1995, 9 (02) :75-77